MAPT and Alzheimer disease: Consistently, a previous study revealed that common neuropsychiatric symptoms such as irritability seen in AD patients are the consequence of brain inflammation rather than Aβ and tau pathologies (Schaffer Aguzzoli et al., 2023), and the qPCR results verified the DEGs.